Eyeworld

OCT 2019

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1171786

Contents of this Issue

Navigation

Page 65 of 78

OCTOBER 2019 | EYEWORLD | 63 C Contact information Sheppard: jsheppard@vec2020.com Rowen: srowen10@gmail.com Gupta: preeyakgupta@gmail.com Periman: lauraperiman@yahoo.com preferable in cases of excessive lid laxity or significant meibomian gland shortening. Dr. Gupta said practices treating many aspects of dry eye can find it helpful to incor- porate various technologies to provide more systematic relief of MGD while providing com- plimentary treatments for the ocular surface. Debridement advantage Lid margin debridement improves the expres- sion of the glands because it cleans off bacteria and sometimes the blockages of the anterior glands, Dr. Rowen said. "It helps to make sure that the pores to the glands are open," Dr. Rowen said. Dr. Gupta said debridement of the lid with a blunt spatula in the clinic can help, but more research is needed on combining microbleph- The iLux uses a single-use tip with an inner pad that slips behind the eyelid and an outer pad that's pressed against the outer surface of the eyelid during heating and compression. Source: Preeya Gupta, MD Reference Hamblin MR. Shining light on the head: Photobiomodulation for brain disorders. BBA Clin. 2016;6:113–124. Relevant financial interests Sheppard: None Rowen: Alcon, Johnson & Johnson Vision Gupta: Alcon, Johnson & Johnson Vision Periman: Allergan, Bruder Healthcare, Eyedetec, Johnson & Johnson Vision, Novartis, ScienceBased Health, Sun aroexfoliation with the meibomian expression procedure. Home option? Views on home use of iLux were split among surgeons using the device. Both Dr. Gupta and Dr. Rowen viewed patient self-use of the device as unlikely to provide reliable results. However, Dr. Sheppard said he didn't see why a perceptive and dexterous family member couldn't be taught how to use it effectively at home or in the setting of an immobile debilitat- ed symptomatic patient. "That might provide another opportunity for the manufacturer," Dr. Sheppard said. "You don't need excessive understanding to use the iLux."

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - OCT 2019